Back to Search
Start Over
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response
- Source :
- Circulation. Cardiovascular genetics. 10(1)
- Publication Year :
- 2016
-
Abstract
- Background— Thiazide diuretics are among the most commonly prescribed antihypertensives. However, Methods and Results— Genome-wide analysis included 228 white hypertensives with BP determined at baseline and after 9 weeks of hydrochlorothiazide. Single-nucleotide polymorphisms with P − 5 were prioritized according to their biological function, using RegulomeDB, haploreg, and Genome-Wide Annotation of Variants. The results from the prioritization approach revealed rs10995 as the most likely functional single-nucleotide polymorphism, among single-nucleotide polymorphisms tested, that has been associated with hydrochlorothiazide BP response. The rs10995 G -allele was associated with better BP response to hydrochlorothiazide versus noncarriers (Δ systolic BP/Δ diastolic BP: −12.3/−8.2 versus −6.8/−3.5 mm Hg, respectively, Δ systolic BP P =3×10 −4 , Δ diastolic BP P =5×10 −5 ). This association was replicated in independent participants treated with chlorthalidone. In addition, rs10995 G-allele was associated with increased mRNA expression of VASP (vasodilator-stimulated phosphoprotein). Moreover, baseline expression of the VASP mRNA was significantly higher in 25 good responders to hydrochlorothiazide compared with 25 poor responders ( P =0.01). This finding was replicated in independent participants treated with chlorthalidone ( P =0.04). Last, allelic-specific expression analysis revealed a significant but modest imbalance with rs10995 and rs10156, a single-nucleotide polymorphism in high linkage disequilibrium ( r 2 =0.7) with rs10995, which both could contribute to the observed genetic effects by affecting VASP mRNA expression. Conclusions— This study highlights the strength of using different omics to identify novel biomarkers of drug response and suggests VASP as a potential determinant of thiazide diuretics BP response. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifiers: NCT00246519 and NCT01203852.
- Subjects :
- 0301 basic medicine
Male
Time Factors
Pharmacogenomic Variants
Sodium Chloride Symporter Inhibitors
Blood Pressure
Bioinformatics
Linkage Disequilibrium
Hydrochlorothiazide
Prospective Studies
Genetics (clinical)
Microfilament Proteins
Middle Aged
Up-Regulation
Phenotype
Treatment Outcome
Hypertension
Chlorthalidone
Female
Cardiology and Cardiovascular Medicine
medicine.drug
Adult
medicine.medical_specialty
Genotype
Diastole
Biology
Polymorphism, Single Nucleotide
Article
03 medical and health sciences
Internal medicine
Genetics
medicine
Humans
RNA, Messenger
Allele
Thiazide
Antihypertensive Agents
Gene Expression Profiling
Omics
Phosphoproteins
030104 developmental biology
Blood pressure
Endocrinology
Pharmacogenetics
Transcriptome
Cell Adhesion Molecules
Genome-Wide Association Study
Subjects
Details
- ISSN :
- 19423268
- Volume :
- 10
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Circulation. Cardiovascular genetics
- Accession number :
- edsair.doi.dedup.....600068986ba48dd7484d13da87d3a827